1173 - Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for access to erlotinib

Page last updated: 13 July 2016

Application Detail

Status

Closed

Description of Medical Service

-

Description of Medical Condition

-

Reason for Application

-

Medical Service Type

-

Previous Application Number

Not Applicable

Associated Documentation

Application Form

-

PICO Confirmation

Final Decision Analytic Protocol (PDF 412 KB)
Final Decision Analytic Protocol (Word 818 KB)

Assessment Report

-

Public Summary Document

Public Summary Document - August 2012 (PDF 116 KB)
Public Summary Document - August 2012 (Word 691 KB)

Public Summary Document - August 2013 (PDF 136 KB)
Public Summary Document - August 2013 (Word 103 KB)

Meetings for this Application

PASC

14 - 15 September 2011
1 - 2 December 2011

ESC

-

MSAC

2 August 2012
1 August 2013